FARMAKON: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FARMAKON
Largest movements
- Current investments +€248,361
up €248,361 (+577%), from €43,032 to €291,393
- Cash -€225,555
down €225,555 (-89.3%), from €252,652 to €27,097
mainly Current investments (-€248,361) and Contributions, distributions and other (-€55,789)
- Other debts +€27,421
up €27,421 (+410%), from €6,692 to €34,113
- Tax, wage and social debts -€9,696
down €9,696 (-33.4%), from €29,023 to €19,326
- Taxes +€4,078
up €4,078 (+18.1%), from €22,508 to €26,586
- Financial income +€1,913
up €1,913, from €0 to €1,913
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €717,334 | €736,423 | +€19,089 | +2.7% |
| Fixed assets | 21/28 | €404,085 | €404,085 | = | 0.0% |
| Financial fixed assets | 28 | €404,085 | €404,085 | = | 0.0% |
| Current assets | 29/58 | €313,249 | €332,338 | +€19,089 | +6.1% |
| Amounts receivable within one year | 40/41 | €16,775 | €13,427 | -€3,348 | -20.0% |
| Other amounts receivable | 41 | €16,775 | €13,427 | -€3,348 | -20.0% |
| Current investments | 50/53 | €43,032 | €291,393 | +€248,361 | +577% |
| Cash at bank and in hand | 54/58 | €252,652 | €27,097 | -€225,555 | -89.3% |
| Deferred charges and accrued income | 490/1 | €790 | €421 | -€369 | -46.7% |
| Total equity and liabilities | 10/49 | €717,334 | €736,423 | +€19,089 | +2.7% |
| Equity | 10/15 | €680,765 | €680,844 | +€79 | 0.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €662,165 | €662,244 | +€79 | 0.0% |
| Distributable reserves | 133 | €662,165 | €662,244 | +€79 | 0.0% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €36,569 | €55,579 | +€19,010 | +52.0% |
| Amounts payable within one year | 42/48 | €35,979 | €55,579 | +€19,600 | +54.5% |
| Trade debts | 44 | €264 | €2,139 | +€1,876 | +711% |
| Suppliers | 440/4 | €264 | €2,139 | +€1,876 | +711% |
| Taxes, remuneration and social security | 45 | €29,023 | €19,326 | -€9,696 | -33.4% |
| Taxes | 450/3 | €29,023 | €19,326 | -€9,696 | -33.4% |
| Other amounts payable | 47/48 | €6,692 | €34,113 | +€27,421 | +410% |
| Accrued charges and deferred income | 492/3 | €590 | - | -€590 | |
| Other operating charges | 640/8 | €2,889 | €3,080 | +€191 | +6.6% |
| Gross operating margin | 9900 | €84,751 | €84,101 | -€650 | -0.8% |
| Operating profit (loss) | 9901 | €81,862 | €81,022 | -€840 | -1.0% |
| Financial income | 75/76B | €0 | €1,913 | +€1,913 | |
| Recurring financial income | 75 | €0 | €1,913 | +€1,913 | |
| Financial charges | 65/66B | €30 | €480 | +€450 | +1,502% |
| Recurring financial charges | 65 | €30 | €480 | +€450 | +1,502% |
| Profit (loss) for the period before taxes | 9903 | €81,832 | €82,454 | +€622 | +0.8% |
| Income taxes | 67/77 | €22,508 | €26,586 | +€4,078 | +18.1% |
| Profit (loss) for the period | 9904 | €59,324 | €55,869 | -€3,455 | -5.8% |
| Profit (loss) for the period to be appropriated | 9905 | €59,324 | €55,869 | -€3,455 | -5.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.